Energy Supplement Recalled Over Undeclared ED Drug

Akkarco LLC's Ashfiat Alharamain Energy Support supplement has been urgently recalled after FDA lab tests detected tadalafil, a prescription-strength erectile dysfunction drug, posing serious health risks.

Baby Esme's Silent Birth: A Father's Fight

Josh Richardson recounts the harrowing birth of his daughter Esme, who suffered meconium aspiration and was saved by an ECMO machine, inspiring his charity run.

Teen's Headache Battle Reveals Terminal Brain Tumour

Max Hall, 14, endured daily headaches for over a year before scans confirmed a grade-4 diffuse glioma. His family now fights for experimental treatments while highlighting UK brain tumour research gaps.

NHS trial of Zeus Sleep device for sleep apnoea

The NHS is trialling the Zeus Sleep device, a chin-worn alternative to CPAP machines, offering hope to millions with sleep apnoea by using electrical stimulation to improve sleep quality.

Hims & Hers Launches $49 Wegovy Pill Copy

Telehealth firm Hims & Hers offers compounded semaglutide pills at $49 monthly, significantly cheaper than Novo Nordisk's Wegovy, sparking market reaction and regulatory scrutiny.

Honey Energy Supplement Recalled for Hidden ED Drug

US health officials have issued a nationwide recall for Ashfiat Alharamain Energy Support after tests revealed undisclosed prescription-strength erectile dysfunction medication tadalafil in the honey-based supplement.

Apple Watch NHS Rollout Urged for Heart Patients

Leading experts call for Apple smartwatches to be available on the NHS for atrial fibrillation patients after a study shows they slash hospital readmissions and improve detection.

Page 1 of 649